The three National Biotechnology Institutes are:
- Malaysia Agro-Biotechnology Institute (ABI)
- Malaysia Institute of Pharmaceuticals and Nutraceuticals (IPHARM)
- Malaysia Genome Institute (MGI).
In 2011, the institutes were restructured and placed under an autonomous organization called the National Institutes of Biotechnology Malaysia (NIBM). While the three institutes focus on high quality and market driven R&D and innovations, NIBM’s key role is to support and spearhead the commercialization of the R&D activities at the institutes based on industry requirements.
NIBM was eventually registered on 27 January 2012 as a Company Limited by Guarantee (CLG) not for profit under the purview of rhe Ministry of Science, Technology and Innovation (MOSTI) and began operations on 1st March 2012.
